Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei

World J Surg Oncol. 2024 May 21;22(1):134. doi: 10.1186/s12957-024-03412-7.

Abstract

Background: Appendiceal pseudomyxoma peritonei (PMP), a rare tumor from mucinous appendiceal origins, is treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). However, tubing blockages during HIPEC treatment pose a common challenge, impeding the smooth progression of therapy. Few studies to date have explored the incidence and risk factors of tube occlusion during HIPEC in patients with appendiceal PMP, as well as its adverse impact on postoperative complications.

Methods: From October 2017 to June 2023, a total of 80 patients with appendiceal PMP undergoing combined CRS and HIPEC were included in this study. Tubing blockage events were strictly defined, with patients experiencing blockages during HIPEC treatment allocated to the study group, while those with unobstructed perfusion were assigned to the control group. A comparative analysis was conducted between the two groups regarding post-HIPEC health assessments and occurrence of complications. Risk factors for luminal occlusion during closed HIPEC procedures were identified through univariate and multivariate analysis of data from 303 HIPEC treatments.

Results: Tubing blockages occurred in 41 patients (51.3%). The study group experienced prolonged gastrointestinal decompression time (4.1 ± 3.0 vs. 2.5 ± 1.7 days, P = 0.003) and prolonged time to bowel movement (6.1 ± 2.3 vs. 5.1 ± 1.8 days, P = 0.022) compared to the control group. There was no significant difference in the incidence of complications between the two groups. The 1-year survival rate postoperatively was 97%, and the 3-year survival rate was 81%, with no association found between tubing blockage and poorer survival. Additionally, In 303 instances of HIPEC treatment among these 80 patients, tube occlusion occurred in 89 cases (89/303, 29.4%). Multivariable logistic regression analysis revealed age, diabetes, hypertension, and pathology as independent risk factors for tube occlusion.

Conclusion: Tubing blockages are a common occurrence during HIPEC treatment, leading to prolonged postoperative gastrointestinal functional recovery time. When patients are elderly and have concomitant hypertension and diabetes, along with a histological type of low-grade mucinous tumor, the risk of tube occlusion increases. However, this study did not find a significant correlation between tubing blockage and the incidence of postoperative complications or overall patient survival.

Keywords: Complication; Gastrointestinal function; HIPEC; Tube occlusion.

MeSH terms

  • Adult
  • Aged
  • Appendiceal Neoplasms* / mortality
  • Appendiceal Neoplasms* / pathology
  • Appendiceal Neoplasms* / therapy
  • Combined Modality Therapy
  • Cytoreduction Surgical Procedures* / adverse effects
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperthermia, Induced / adverse effects
  • Hyperthermia, Induced / methods
  • Hyperthermic Intraperitoneal Chemotherapy* / adverse effects
  • Hyperthermic Intraperitoneal Chemotherapy* / methods
  • Male
  • Middle Aged
  • Peritoneal Neoplasms* / pathology
  • Peritoneal Neoplasms* / therapy
  • Postoperative Complications* / etiology
  • Prognosis
  • Pseudomyxoma Peritonei* / pathology
  • Pseudomyxoma Peritonei* / therapy
  • Retrospective Studies
  • Risk Factors
  • Survival Rate